Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
Condition: ITP Intervention: Drug: TPO Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Thrombocytopenia